Diapulse

Diapulse™

Energy medicine
A therapeutic device that uses radio waves to produce short, intense electromagnetic pulses, which penetrate into deep tissues; the heat generated by these pulses is believed to improve blood flow, reduce pain, oedema and inflammation and promote healing.
Mentioned in ?
References in periodicals archive ?
High-powered pulsed electromagnetic field (PEMF) generators, such as a Diapulse Model 103, appear to be very helpful for migraine headaches (but not tension headaches), according to the review authors.
Ogilvie-Harris and Gilbart's review (1995) found preliminary evidence that cryotherapy and diapulse (diathermy) are of benefit after ankle sprain but no evidence to support the use of ultrasound and laser therapy.
Despite the preliminary evidence reported from Ogilvie-Harris and Gilbart (1995), none of the included studies in the current review employed a diapulse intervention and there was little evidence to support the use of rest, ice, compression, or elevation when applied as isolated components (ie, compression alone) or as intervention combinations such as ice and compression.
Relatively high-power devices, such as the Diapulse Model 103 (Diapulse Corporation of America, Great Neck, New York) that produces sufficient power to light a 40 W lightbulb placed within its field, are designed for use several times a day.
Diapulse(R) Corporation of America (OTC- DIAC) announced today that the Centers for Medicare and Medicaid Services (CMS) October 2004 quarterly update takes effect today which allows a Skilled Nursing Facility (SNF) and Home Health (HH) to use the new Diapulse electromagnetic therapy code in the Healthcare Common Procedure Code System (HCPCS), for Consolidated Billing Enforcement.
Finally, a new wound-care specialist took time to do a lot of research and came up with the idea of using the Diapulse.
Diapulse Corporation of America (OTC- DIAC) announced today that based on a recent decision the Centers for Medicare and Medicaid Services (CMS) will begin Medicare coverage implementation today for the Diapulse Wound Treatment System.
This article specifically discusses the use of Diapulse, a device that directs a pulsed-electromagnetic field (PEMF) to an area of injury.
Diapulse is a registered trademark of Diapulse Corporation of America.
After I had two flap surgeries and was told by a highly respected clinic that another operation and three weeks in the hospital were required, the wound nurse suggested I try the Diapulse machine.
Diapulse Corporation of America (OTC- DIAC) announced today that Centers for Medicare and Medicaid Services (CMS) will issue a National Coverage Determination (NCD) providing coverage for the Diapulse Wound Treatment System, with an effective date July 1, 2004.
Diapulse Corporation of America (OTC- DIAC) announced today that Centers for Medicare and Medicaid (CMS) Services granted approval for coverage of the Diapulse Wound Treatment System in a Decision Memorandum issued December 22, 2003.